“…Patients with ALS8 have predominant lower motor neuron involvement, with symptoms including progressive muscle weakness (mainly in the lower limbs), muscle atrophy, cramp, tremor, fasciculations, pain, abdominal protrusion, autonomic dysfunction (e.g. choking, constipation), and subtle cognitive and behavioural impairments ( Nishimura et al, 2004a , 2004b ; Marques et al, 2006 ; Funke et al, 2010 ; Kosac et al, 2013 ; Di et al, 2016 ; Chadi et al, 2017 ; Sun et al, 2017 ; Guber et al, 2018 ; de Alcântara et al, 2019 ; Trilico et al, 2020 ; Nunes Gonçalves et al, 2021 ; Temp et al, 2021 ; Leoni et al, 2022 ). ALS8’s clinical heterogeneity manifests not only in the symptoms but also in the age of onset (reported at 20–57 years) and the disease progression (rapid [<5 years] to slow [30+ years]).…”